BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8864481)

  • 1. Effect of chronic dexfenfluramine on Fos in rat brain.
    Li BH; Rowland NE
    Brain Res; 1996 Jul; 728(2):188-92. PubMed ID: 8864481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
    Laflamme N; Bovetto S; Richard D; Rivest S
    Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain.
    Li BH; Rowland NE
    Regul Pept; 1994 Mar; 50(3):223-33. PubMed ID: 8016407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vagotomy on cholecystokinin- and dexfenfluramine-induced Fos-like immunoreactivity in the rat brain.
    Li BH; Rowland NE
    Brain Res Bull; 1995; 37(6):589-93. PubMed ID: 7670882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally and centrally administered bombesin induce Fos-like immunoreactivity in different brain regions in rats.
    Li BH; Rowland NE
    Regul Pept; 1996 Apr; 62(2-3):167-72. PubMed ID: 8795081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexfenfluramine and norfenfluramine: comparison of mechanism of action in feeding and brain Fos-ir studies.
    Rowland NE; Roth JD; McMullen MR; Patel A; Cespedes AT
    Am J Physiol Regul Integr Comp Physiol; 2000 Feb; 278(2):R390-9. PubMed ID: 10666140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain.
    Richard D; Rivest S; Rivier C
    Brain Res; 1992 Oct; 594(1):131-7. PubMed ID: 1467932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats.
    Rowland NE; Robertson K; Lo J; Rema E
    Psychopharmacology (Berl); 2001 Jun; 156(1):108-14. PubMed ID: 11465628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice.
    Rowland NE; Robertson K; Green DJ
    Physiol Behav; 2003 Feb; 78(2):295-301. PubMed ID: 12576128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of dexfenfluramine-induced anorexia and c-Fos/c-Jun expression by lesion in the lateral parabrachial nucleus.
    Li BH; Spector AC; Rowland NE
    Brain Res; 1994 Mar; 640(1-2):255-67. PubMed ID: 8004454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions.
    Javed A; Van De Kar LD; Gray TS
    Brain Res; 1997 Nov; 774(1-2):94-105. PubMed ID: 9452197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats.
    Li BH; Rowland NE
    Brain Res Bull; 1993; 31(1-2):43-8. PubMed ID: 8453494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Fos induced in rat brain by GLP-1 and amylin.
    Rowland NE; Crews EC; Gentry RM
    Regul Pept; 1997 Aug; 71(3):171-4. PubMed ID: 9350975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between anorexia and loss of serotonin uptake sites in brain of mice and rats receiving d-norfenfluramine or d-fenfluramine.
    Rowland NE; Rokadia S; Green DJ; Robertson K
    Pharmacol Biochem Behav; 2004 Mar; 77(3):541-6. PubMed ID: 15006465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
    Buller KM; Hamlin AS; Osborne PB
    Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Area postrema and the anorectic actions of dexfenfluramine and amylin.
    Rowland NE; Richmond RM
    Brain Res; 1999 Feb; 820(1-2):86-91. PubMed ID: 10023034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration.
    Chang SL; Patel NA; Romero AA
    Brain Res; 1995 May; 679(1):89-98. PubMed ID: 7648269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain fos-like immunoreactivity in chronic decerebrate and neurologically intact rats given 2,5-anhydro-D-mannitol.
    Horn CC; Kaplan JM; Grill HJ; Friedman MI
    Brain Res; 1998 Aug; 801(1-2):107-15. PubMed ID: 9729312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Fos in rat brain in relation to sodium appetite: furosemide and cerebroventricular renin.
    Rowland NE; Fregly MJ; Han L; Smith G
    Brain Res; 1996 Jul; 728(1):90-6. PubMed ID: 8864301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of 5-Ht3 receptors in the septal area increases Fos expression in selected brain areas.
    Urzedo-Rodrigues LS; Ferreira HS; Santana RC; Luz CP; Perrone CF; Fregoneze JB
    Auton Neurosci; 2014 Apr; 181():55-68. PubMed ID: 24507935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.